Stock Earnings

Question 1

Bicycle Therapeutics PLC의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Bicycle Therapeutics PLC의 총 자산은 $956이며, 순loss입니다.

Question 2

BCYC의 주요 재무 비율은 무엇인가요?

Accepted Answer

Bicycle Therapeutics PLC의 유동비율은 5.86이고, 순이익률은 -482.85, 주당 매출은 $0.6입니다.

Question 3

Bicycle Therapeutics PLC의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Bicycle Therapeutics PLC largest revenue segment is Chemically Synthesized Medicines, at a revenue of 35,275,000 in the most earnings release.For geography, United Kingdom is the primary market for Bicycle Therapeutics PLC, at a revenue of 35,275,000.

Question 4

Bicycle Therapeutics PLC은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Bicycle Therapeutics PLC의 순loss은 $-169입니다.

Question 5

Bicycle Therapeutics PLC에 부채가 있나요?

Accepted Answer

yes, Bicycle Therapeutics PLC의 부채는 163입니다.

Question 6

Bicycle Therapeutics PLC의 발행 주식은 몇 주인가요?

Accepted Answer

Bicycle Therapeutics PLC의 총 발행 주식은 69.06주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	28	35	26	14	11	10
Revenue Growth (YoY)	-22%	35%	86%	27%	10%	-23%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	80	71	59	48	32	29
Research & Development	238	172	156	81	44	33
Operating Expenses	314	244	216	130	77	62
Other Non Operating Income (Expenses)	--	--	--	--	--	0
Pretax Income	-252	-173	-179	-114	-68	-51
Income Tax Expense	-2	-4	1	-1	-1	0
Net Income	-250	-169	-180	-112	-66	-51
Net Income Growth	51%	-6%	61%	70%	28.99%	70%
Shares Outstanding (Diluted)	69.3	58.2	35.59	29.66	25.06	19.15
Shares Change (YoY)	0%	64%	20%	18%	31%	73%
EPS (Diluted)	-3.62	-2.9	-5.07	-3.8	-2.67	-2.66
EPS Growth	50%	-43%	34%	42%	0%	-4%
Free Cash Flow	-241	-165	-63	-105	-16	-18
Free Cash Flow Per Share	-3.47	-2.83	-1.77	-3.54	-0.63	-0.93
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,017.85%	-597.14%	-726.92%	-828.57%	-590.9%	-520%
Profit Margin	-892.85%	-482.85%	-692.3%	-800%	-600%	-509.99%
Free Cash Flow Margin	-860.71%	-471.42%	-242.3%	-750%	-145.45%	-180%
EBITDA	-279	-202	-183	-113	-64	-51
EBITDA Margin	-996.42%	-577.14%	-703.84%	-807.14%	-581.81%	-509.99%
D&A For EBITDA	6	7	6	3	1	1
EBIT	-285	-209	-189	-116	-65	-52
EBIT Margin	-1,017.85%	-597.14%	-726.92%	-828.57%	-590.9%	-520%
Effective Tax Rate	0.79%	2.31%	-0.55%	0.87%	1.47%	0%

Bicycle Therapeutics PLC (BCYC) Price

BCYC Stock Price Chart

BCYC Income

Follow-Up Questions